AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · IEX Real-Time Price · USD
7.18
+0.23 (3.31%)
At close: Jul 19, 2024, 4:00 PM
7.26
+0.08 (1.11%)
Pre-market: Jul 22, 2024, 5:22 AM EDT
AngioDynamics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for AngioDynamics stock have an average target of 12.25, with a low estimate of 10 and a high estimate of 14. The average target predicts an increase of 70.61% from the current stock price of 7.18.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AngioDynamics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $18 → $13 | Strong Buy | Maintains | $18 → $13 | +81.06% | Jul 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +94.99% | Jul 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +94.99% | May 22, 2024 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $12 | Hold → Buy | Upgrades | $12 | +67.13% | Apr 5, 2024 |
| Raymond James | Raymond James | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +39.28% | Jan 9, 2024 |
Financial Forecast
Revenue This Year
293.05M
from 338.75M
Decreased by -13.49%
Revenue Next Year
293.00M
from 293.05M
Decreased by -0.02%
EPS This Year
-0.53
from -1.33
EPS Next Year
-0.50
from -0.53
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 319.2M | 304.5M | 330.1M | 366.3M | 407.6M |
| Avg | 293.1M | 293.0M | 320.7M | 355.8M | 396.0M |
| Low | 265.4M | 280.3M | 308.1M | 341.8M | 380.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -5.8% | 3.9% | 12.7% | 14.2% | 14.6% |
| Avg | -13.5% | -0.0% | 9.4% | 11.0% | 11.3% |
| Low | -21.7% | -4.4% | 5.2% | 6.6% | 6.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.46 | -0.28 | - | 0.26 | 0.58 |
| Avg | -0.53 | -0.50 | - | 0.26 | 0.56 |
| Low | -0.56 | -0.67 | - | 0.25 | 0.54 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 126.5% |
| Avg | - | - | - | - | 120.0% |
| Low | - | - | - | - | 111.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.